224 related articles for article (PubMed ID: 35890347)
1. Brain Delivery of IGF1R5, a Single-Domain Antibody Targeting Insulin-like Growth Factor-1 Receptor.
Yogi A; Hussack G; van Faassen H; Haqqani AS; Delaney CE; Brunette E; Sandhu JK; Hewitt M; Sulea T; Kemmerich K; Stanimirovic DB
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890347
[TBL] [Abstract][Full Text] [Related]
2. Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics.
Alata W; Yogi A; Brunette E; Delaney CE; van Faassen H; Hussack G; Iqbal U; Kemmerich K; Haqqani AS; Moreno MJ; Stanimirovic DB
FASEB J; 2022 Mar; 36(3):e22208. PubMed ID: 35192204
[TBL] [Abstract][Full Text] [Related]
3. Single domain antibody-based vectors in the delivery of biologics across the blood-brain barrier: a review.
Gao Y; Zhu J; Lu H
Drug Deliv Transl Res; 2021 Oct; 11(5):1818-1828. PubMed ID: 33155179
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human.
Zhang W; Liu QY; Haqqani AS; Leclerc S; Liu Z; Fauteux F; Baumann E; Delaney CE; Ly D; Star AT; Brunette E; Sodja C; Hewitt M; Sandhu JK; Stanimirovic DB
Fluids Barriers CNS; 2020 Jul; 17(1):47. PubMed ID: 32698806
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1.
Stocki P; Szary J; Rasmussen CLM; Demydchuk M; Northall L; Logan DB; Gauhar A; Thei L; Moos T; Walsh FS; Rutkowski JL
FASEB J; 2021 Feb; 35(2):e21172. PubMed ID: 33241587
[TBL] [Abstract][Full Text] [Related]
6. Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.
Choi ES; Shusta EV
Expert Opin Drug Deliv; 2023; 20(12):1789-1800. PubMed ID: 38007619
[TBL] [Abstract][Full Text] [Related]
7. The 46.1 Antibody Mediates Neurotensin Uptake into the CNS and the Effects Depend on the Route of Intravenous Administration.
Georgieva JV; Katt M; Ye Z; Umlauf BJ; Wenthur CJ; Shusta EV
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015332
[TBL] [Abstract][Full Text] [Related]
8. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1.
Webster CI; Caram-Salas N; Haqqani AS; Thom G; Brown L; Rennie K; Yogi A; Costain W; Brunette E; Stanimirovic DB
FASEB J; 2016 May; 30(5):1927-40. PubMed ID: 26839377
[TBL] [Abstract][Full Text] [Related]
9. A novel platform for engineering blood-brain barrier-crossing bispecific biologics.
Farrington GK; Caram-Salas N; Haqqani AS; Brunette E; Eldredge J; Pepinsky B; Antognetti G; Baumann E; Ding W; Garber E; Jiang S; Delaney C; Boileau E; Sisk WP; Stanimirovic DB
FASEB J; 2014 Nov; 28(11):4764-78. PubMed ID: 25070367
[TBL] [Abstract][Full Text] [Related]
10. VHHs as tools for therapeutic protein delivery to the central nervous system.
Wouters Y; Jaspers T; Rué L; Serneels L; De Strooper B; Dewilde M
Fluids Barriers CNS; 2022 Oct; 19(1):79. PubMed ID: 36192747
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of a blood-brain barrier crossing antibody targeting the cysteine-rich region of IGF1R using hydrogen-exchange mass spectrometry enabled by electrochemical reduction.
Sheff J; Kelly J; Foss M; Brunette E; Kemmerich K; van Faassen H; Raphael S; Hussack G; Comamala G; Rand K; Stanimirovic DB
J Biochem; 2023 Feb; 173(2):95-105. PubMed ID: 36346120
[TBL] [Abstract][Full Text] [Related]
12. Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS.
Georgieva JV; Goulatis LI; Stutz CC; Canfield SG; Song HW; Gastfriend BD; Shusta EV
FASEB J; 2020 Sep; 34(9):12549-12564. PubMed ID: 32960493
[TBL] [Abstract][Full Text] [Related]
13. Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system.
Thom G; Hatcher J; Hearn A; Paterson J; Rodrigo N; Beljean A; Gurrell I; Webster C
MAbs; 2018; 10(2):304-314. PubMed ID: 29182455
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Parkinson's disease with biologics that penetrate the blood-brain barrier via receptor-mediated transport.
Pardridge WM
Front Aging Neurosci; 2023; 15():1276376. PubMed ID: 38035276
[TBL] [Abstract][Full Text] [Related]
15. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
Tashima T
Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
[TBL] [Abstract][Full Text] [Related]
16. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
17. Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening.
Aguiar SI; Dias JNR; André AS; Silva ML; Martins D; Carrapiço B; Castanho M; Carriço J; Cavaco M; Gaspar MM; Nobre RJ; Pereira de Almeida L; Oliveira S; Gano L; Correia JDG; Barbas C; Gonçalves J; Neves V; Aires-da-Silva F
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683891
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier.
Pardridge WM
Front Drug Deliv; 2023; 3():. PubMed ID: 37583474
[TBL] [Abstract][Full Text] [Related]
19. Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody.
Esparza TJ; Su S; Francescutti CM; Rodionova E; Kim JH; Brody DL
Fluids Barriers CNS; 2023 Aug; 20(1):64. PubMed ID: 37620930
[TBL] [Abstract][Full Text] [Related]
20. Engineering and pharmacology of blood-brain barrier-permeable bispecific antibodies.
Stanimirovic D; Kemmerich K; Haqqani AS; Farrington GK
Adv Pharmacol; 2014; 71():301-35. PubMed ID: 25307221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
